These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31587486)

  • 1. Prenatal diagnosis of Desbuquois dysplasia Type 1: Utilization of high-density SNP array to map homozygosity and identify the gene.
    Forster KR; Hooper JE; Blakemore KJ; Baschat AA; Hoover-Fong J
    Am J Med Genet A; 2019 Dec; 179(12):2490-2493. PubMed ID: 31587486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel homozygous variant in CANT1 in a patient with Kim-type Desbuquois dysplasia.
    Menzies L; Cullup T; Calder A; Wilson L; Faravelli F
    Clin Dysmorphol; 2019 Oct; 28(4):219-223. PubMed ID: 31348018
    [No Abstract]   [Full Text] [Related]  

  • 3. Exome sequencing reveals two novel compound heterozygous XYLT1 mutations in a Polish patient with Desbuquois dysplasia type 2 and growth hormone deficiency.
    Jamsheer A; Olech EM; Kozłowski K; Niedziela M; Sowińska-Seidler A; Obara-Moszyńska M; Latos-Bieleńska A; Karczewski M; Zemojtel T
    J Hum Genet; 2016 Jul; 61(7):577-83. PubMed ID: 27030147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desbuquois dysplasia Kim variant: a rare case report syndrome.
    Agrawal N; Srivastava P; Phadke SR
    Clin Dysmorphol; 2021 Jan; 30(1):62-65. PubMed ID: 33136656
    [No Abstract]   [Full Text] [Related]  

  • 5. CANT1 deficiency in a mouse model of Desbuquois dysplasia impairs glycosaminoglycan synthesis and chondrocyte differentiation in growth plate cartilage.
    Kodama K; Takahashi H; Oiji N; Nakano K; Okamura T; Niimi K; Takahashi E; Guo L; Ikegawa S; Furuichi T
    FEBS Open Bio; 2020 Jun; 10(6):1096-1103. PubMed ID: 32277574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel gene (FAM20B encoding glycosaminoglycan xylosylkinase) for neonatal short limb dysplasia resembling Desbuquois dysplasia.
    Kuroda Y; Murakami H; Enomoto Y; Tsurusaki Y; Takahashi K; Mitsuzuka K; Ishimoto H; Nishimura G; Kurosawa K
    Clin Genet; 2019 Jun; 95(6):713-717. PubMed ID: 30847897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XYLT1 mutations in Desbuquois dysplasia type 2.
    Bui C; Huber C; Tuysuz B; Alanay Y; Bole-Feysot C; Leroy JG; Mortier G; Nitschke P; Munnich A; Cormier-Daire V
    Am J Hum Genet; 2014 Mar; 94(3):405-14. PubMed ID: 24581741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desbuquois dysplasia type I and fetal hydrops due to novel mutations in the CANT1 gene.
    Laccone F; Schoner K; Krabichler B; Kluge B; Schwerdtfeger R; Schulze B; Zschocke J; Rehder H
    Eur J Hum Genet; 2011 Nov; 19(11):1133-7. PubMed ID: 21654728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desbuquois dysplasia type II in a patient with a homozygous mutation in XYLT1 and new unusual findings.
    Silveira C; Leal GF; Cavalcanti DP
    Am J Med Genet A; 2016 Nov; 170(11):3043-3047. PubMed ID: 27481334
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel CANT1 mutation in three Indian patients with Desbuquois dysplasia Kim type.
    Singh A; Kim OH; Iida A; Park WY; Ikegawa S; Kapoor S
    Eur J Med Genet; 2015 Feb; 58(2):105-10. PubMed ID: 25486376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diagnosis of Desbuquois dysplasia type 1 by whole exome sequencing before the occurrence of specific ultrasound signs.
    Houdayer C; Ziegler A; Boussion F; Blesson S; Bris C; Toutain A; Biquard F; Guichet A; Bonneau D; Colin E
    J Matern Fetal Neonatal Med; 2021 Jul; 34(13):2217-2220. PubMed ID: 31510824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of CANT1 gene variant in a girl with Desbuquois dysplasia type I].
    Ma J; Yang Y; Zhang K; Huang Y; Lyu Y; Gao M; Gai Z; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Dec; 36(12):1206-1209. PubMed ID: 31813149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification.
    Paganini C; Monti L; Costantini R; Besio R; Lecci S; Biggiogera M; Tian K; Schwartz JM; Huber C; Cormier-Daire V; Gibson BG; Pirog KA; Forlino A; Rossi A
    Matrix Biol; 2019 Aug; 81():70-90. PubMed ID: 30439444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CANT1 mutation is also responsible for Desbuquois dysplasia, type 2 and Kim variant.
    Furuichi T; Dai J; Cho TJ; Sakazume S; Ikema M; Matsui Y; Baynam G; Nagai T; Miyake N; Matsumoto N; Ohashi H; Unger S; Superti-Furga A; Kim OH; Nishimura G; Ikegawa S
    J Med Genet; 2011 Jan; 48(1):32-7. PubMed ID: 21037275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case of Desbuquois dysplasia type 1: potentially lethal skeletal dysplasia.
    Inoue S; Ishii A; Shirotani G; Tsutsumi M; Ohta E; Nakamura M; Mori T; Inoue T; Nishimura G; Ogawa A; Hirose S
    Pediatr Int; 2014 Aug; 56(4):e26-9. PubMed ID: 25252066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel compound heterozygous variants in XYLT1 gene caused Desbuquois dysplasia type 2 in an aborted fetus: a case report.
    Rajabi F; Bereshneh AH; Ramezanzadeh M; Garshasbi M
    BMC Pediatr; 2022 Jan; 22(1):63. PubMed ID: 35081921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis.
    Nizon M; Huber C; De Leonardis F; Merrina R; Forlino A; Fradin M; Tuysuz B; Abu-Libdeh BY; Alanay Y; Albrecht B; Al-Gazali L; Basaran SY; Clayton-Smith J; Désir J; Gill H; Greally MT; Koparir E; van Maarle MC; MacKay S; Mortier G; Morton J; Sillence D; Vilain C; Young I; Zerres K; Le Merrer M; Munnich A; Le Goff C; Rossi A; Cormier-Daire V
    Hum Mutat; 2012 Aug; 33(8):1261-6. PubMed ID: 22539336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two siblings with bilateral congenital knee dislocations: case report].
    Kubinec V; Polakovičová L; Kantarská D
    Acta Chir Orthop Traumatol Cech; 2015; 82(2):161-6. PubMed ID: 26317189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and recurrent XYLT1 mutations in two Turkish families with Desbuquois dysplasia, type 2.
    Guo L; Elcioglu NH; Iida A; Demirkol YK; Aras S; Matsumoto N; Nishimura G; Miyake N; Ikegawa S
    J Hum Genet; 2017 Mar; 62(3):447-451. PubMed ID: 27881841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal Phenotype of Desbuquois Dysplasia.
    Biji IK; Mahay SB; Saxena R; Verma I; Kumar B; Puri RD
    Indian J Pediatr; 2023 Jan; 90(1):83-86. PubMed ID: 36331722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.